Fauna Bio
PrivateLast Round
Series A
Mar 14, 2025
Est. Valuation
$26.31M
Total Funding Raised
$13.7M
Company Overview
Fauna Bio operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Strategic round in December 2023.
Fauna Bio is a biotechnology company that has developed a cross-mammal drug discovery platform to identify novel therapeutics for human diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fauna Bio Comparables
Compare Fauna Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paratus Sciences | 82% | |
| Variant Bio | 81% | |
| Rejuve Biotech | 79% |
For institutional investors. Book with your work email.
Fauna Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 14, 2025 | ||||
| Strategic | Dec 21, 2023 | ||||
| Seed | Sep 21, 2021 | ||||
| Grant | Mar 4, 2021 | ||||
| Grant | Oct 9, 2019 | ||||
Seed | Apr 11, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fauna Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pacific 8 Ventures | Seed |
| NIH RADx | Grant |
| age1 | Seed |
| Boom Capital | Seed |
| Lifeforce Capital | Seed |
| Beagle Ventures | Seed |
| Longevity Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2025
Attended BIO International Convention and introduced a new product.
- Jun 16, 2025
Introduced a new therapy delivery product at BIO International Convention.
For institutional investors. Book with your work email.
Fauna Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fauna Bio's valuation, stock price, and market status.
Is Fauna Bio a public or private company?
Fauna Bio is a private company.
What is the current stock price of Fauna Bio?
Fauna Bio is a private company, so its shares have no public market price. Caplight tracks Fauna Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fauna Bio worth (valuation)?
Fauna Bio's valuation is estimated at $26.3M based on funding round data.
Can I buy Fauna Bio stock?
Fauna Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fauna Bio's last funding round?
Fauna Bio's most recent funding round was Series A on March 14, 2025.
Who are the main investors in Fauna Bio?
Key investors in Fauna Bio include Lifeforce Capital, True Ventures.
Will Fauna Bio IPO soon?
No public IPO plans have been announced for Fauna Bio.
How can I track Fauna Bio secondary market activity?
Caplight tracks bids, offers, and trades in Fauna Bio's shares on secondary markets.